BR112013031791A2 - derivados de ftalazinona-pirrolopirimidinacarboxamida - Google Patents

derivados de ftalazinona-pirrolopirimidinacarboxamida

Info

Publication number
BR112013031791A2
BR112013031791A2 BR112013031791A BR112013031791A BR112013031791A2 BR 112013031791 A2 BR112013031791 A2 BR 112013031791A2 BR 112013031791 A BR112013031791 A BR 112013031791A BR 112013031791 A BR112013031791 A BR 112013031791A BR 112013031791 A2 BR112013031791 A2 BR 112013031791A2
Authority
BR
Brazil
Prior art keywords
pyrrolopyrimidinecarboxamide
phthalazinone
derivatives
compounds
formula
Prior art date
Application number
BR112013031791A
Other languages
English (en)
Inventor
Mann Alexander
Pahl Andreas
Hatzelmann Armin
Hesslinger Christian
Zitt Christof
Flockerzi Dieter
Benediktus Ewald
Christof Holst Hans
Tenor Hermann
Stadlwieser Josef
Hessmann Manuela
Viertelhaus Martin
Hussong Ragna
Hummel Rolf-Peter
Maier Thomas
Stengel Thomas
Kanacher Tobias
Dunkern Torsten
Original Assignee
Takeda Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44764312&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112013031791(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Gmbh filed Critical Takeda Gmbh
Publication of BR112013031791A2 publication Critical patent/BR112013031791A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

resumo patente de invenção: "derivados de ftalazinona-pirrolopirimidinacarboxamida". a presente invenção refere-se aos compostos de fórmula (1), em que r1, r7, r8, r9, r10, r17, r18, r19, r20 e m têm os significados de acordo com a descrição fornecida, são novos inibidores da fosfodiesterase tipo 4 e 5.
BR112013031791A 2011-06-17 2012-06-12 derivados de ftalazinona-pirrolopirimidinacarboxamida BR112013031791A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11170440 2011-06-17
PCT/EP2012/061084 WO2012171900A1 (en) 2011-06-17 2012-06-12 Novel phthalazinone-pyrrolopyrimidinecarboxamide derivatives

Publications (1)

Publication Number Publication Date
BR112013031791A2 true BR112013031791A2 (pt) 2017-01-31

Family

ID=44764312

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013031791A BR112013031791A2 (pt) 2011-06-17 2012-06-12 derivados de ftalazinona-pirrolopirimidinacarboxamida

Country Status (21)

Country Link
US (2) US20140112945A1 (pt)
EP (1) EP2721030B1 (pt)
JP (1) JP5980318B2 (pt)
KR (1) KR20140037195A (pt)
CN (1) CN103582644B (pt)
AR (1) AR086915A1 (pt)
AU (1) AU2012269133A1 (pt)
BR (1) BR112013031791A2 (pt)
CA (1) CA2837248A1 (pt)
CL (1) CL2013003556A1 (pt)
CO (1) CO6852074A2 (pt)
CR (1) CR20130656A (pt)
DO (1) DOP2013000298A (pt)
EA (1) EA023713B1 (pt)
EC (1) ECSP13013076A (pt)
ES (1) ES2564882T3 (pt)
MA (1) MA35269B1 (pt)
MX (1) MX2013014888A (pt)
PE (1) PE20140648A1 (pt)
TN (1) TN2013000439A1 (pt)
WO (1) WO2012171900A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3209314B1 (en) 2015-04-09 2021-11-10 Galderma S.A. A pharmaceutical composition and the use thereof
JP6820273B2 (ja) 2015-04-09 2021-01-27 ガルデルマ・ソシエテ・アノニム インジゴ・ナチュラリス由来のエキス及びそれを調製する方法
US10668120B2 (en) 2015-04-09 2020-06-02 Galderma Sa Antibacterial indigo naturalis or indigo-producing plant extract and use thereof

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
EP0407028B2 (en) 1989-05-31 1999-07-07 FISONS plc Medicament inhalation device and formulation
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
DE69131867T2 (de) 1990-03-23 2000-05-18 Minnesota Mining & Mfg Anwendung von löslichen fluorhaltigen Tensiden zur Herstellung von Aerosol-Präparaten mit dosierter Abgabe
CA2094266C (en) 1990-10-18 1999-06-01 Robert K. Schultz Aerosol formulations of beclomethasone-17,21-dipropionate
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
GB9213874D0 (en) 1992-06-30 1992-08-12 Fisons Plc Process to novel medicament form
GB9306703D0 (en) 1993-03-31 1993-05-26 Fisons Plc Inhalation device
IL111194A (en) 1993-10-08 1998-02-08 Fisons Plc Process for the production of drug patramulations
WO1998031674A1 (en) * 1997-01-15 1998-07-23 Byk Gulden Lomberg Chemische Fabrik Gmbh Phthalazinones
US6255303B1 (en) * 1998-03-14 2001-07-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phthalazinone PDE III/IV inhibitors
EP1102579B1 (de) 1998-08-04 2003-03-19 Jago Research Ag Medizinische aerosolformulierungen
US6397838B1 (en) 1998-12-23 2002-06-04 Battelle Pulmonary Therapeutics, Inc. Pulmonary aerosol delivery device and method
BR0009992A (pt) 1999-04-23 2002-01-08 Battelle Memorial Institute Pulverizador de aerossol eletro-hidrodinâmico, aparelho e processo para administrar um aerossol e processo para produzir e administrar um aerossol
EP1194244B1 (en) 1999-04-23 2005-12-21 Battelle Memorial Institute Directionally controlled ehd aerosol sprayer
AU6233201A (en) * 2000-06-05 2001-12-17 Byk Gulden Lomberg Chem Fab Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
ATE320242T1 (de) 2000-10-09 2006-04-15 3M Innovative Properties Co Medizinische aerosolzusammensetzung
EA200300836A1 (ru) 2001-02-15 2004-02-26 Алтана Фарма Аг Производные фталазинон-пиперидина в качестве ингибиторов pde4
CA2445233A1 (en) 2001-04-25 2002-10-31 Altana Pharma Ag Phthalazinones derivatives useful as pde4/7 inhibitors
CA2494650A1 (en) * 2002-08-10 2004-03-04 Altana Pharma Ag Pyridazinone-derivatives as pde4 inhibitors
AU2003255376A1 (en) 2002-08-10 2004-03-11 Altana Pharma Ag Piperidine-derivatives as pde4 inhibitors
JP4555684B2 (ja) 2002-08-10 2010-10-06 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｐｄｅ４阻害剤としての、ピロリジンジオンにより置換されたピペリジン−フタラゾン
CA2512819A1 (en) * 2003-01-14 2004-07-29 Altana Pharma Ag Pde4 inhibitors for the treatment of neoplasms of lymphoid cells
AU2005210042B2 (en) 2004-02-04 2011-04-21 Takeda Gmbh 2-(piperidin-4-yl) -4, 5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors
WO2005075457A1 (en) 2004-02-04 2005-08-18 Altana Pharma Ag Phthalazinone-derivatives as pde4 inhibitors
AR070454A1 (es) 2008-02-27 2010-04-07 Nycomed Gmbh Pirrolopirimidincarboxamidas y composiciones farmaceuticas que las comprenden
AR077898A1 (es) * 2009-08-26 2011-09-28 Nycomed Gmbh Metilpirrolopirimidincarboxamidas

Also Published As

Publication number Publication date
ECSP13013076A (es) 2014-01-31
WO2012171900A1 (en) 2012-12-20
CA2837248A1 (en) 2012-12-20
JP2014517021A (ja) 2014-07-17
TN2013000439A1 (en) 2015-03-30
MA35269B1 (fr) 2014-07-03
CR20130656A (es) 2014-02-18
MX2013014888A (es) 2014-02-27
AR086915A1 (es) 2014-01-29
DOP2013000298A (es) 2014-03-31
CN103582644A (zh) 2014-02-12
US20140112945A1 (en) 2014-04-24
US20160108049A1 (en) 2016-04-21
ES2564882T3 (es) 2016-03-29
CN103582644B (zh) 2016-07-20
CL2013003556A1 (es) 2014-06-13
EA023713B1 (ru) 2016-07-29
CO6852074A2 (es) 2014-01-30
PE20140648A1 (es) 2014-05-30
JP5980318B2 (ja) 2016-08-31
EP2721030B1 (en) 2015-12-16
EP2721030A1 (en) 2014-04-23
EA201400001A1 (ru) 2014-05-30
AU2012269133A1 (en) 2014-01-30
KR20140037195A (ko) 2014-03-26

Similar Documents

Publication Publication Date Title
BR112012033350A2 (pt) "composição e métodos para modular a via de sinalização de wnt"
PE20151781A1 (es) Piridonamidas como moduladores de canales de sodio
CR20130470A (es) INHIBIDORES DE QUINASA RELACIONADOS CON PIRROLO [2,3-d]PIRIMIDINA TROMPOMIOSINA
CU20090017A7 (es) Peptidomimeticos de smac utiles como inhibidores de proteinas de apoptosis (iap)
BR112014001801A2 (pt) indazóis
ATE542813T1 (de) 6-substituierte 2- heterocyclylaminopyrazinverbindungen als chk-1- inhibitoren
SV2010003472A (es) Compuestos de pirazol
IN2014CN04530A (pt)
ECSP10010271A (es) Derivados de tiazol usados como inhibidores de pi 3-cinasa
BR112013025732A2 (pt) composto de imidazo-oxazina ou sal do mesmo
BR112012026004A2 (pt) derivados de ariletinila
EA201290800A1 (ru) Гетероциклическое соединение
BR112013031405A2 (pt) piridopirazinas substituídas como novos inibidores de syk
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
CR20130419A (es) Derivados heterocíclicos de amina
EA201291217A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПРОИЗВОДНЫЕ 1-(β-D-ГЛЮКОПИРАНОЗИЛ)-2-ТИЕНИЛМЕТИЛБЕНЗОЛА КАК ИНГИБИТОРЫ НЗПГ
EA201590296A1 (ru) Дейтерированный ибрутиниб
BR112014028991A2 (pt) triazóis como inibidores de kv3
BR112015012825A2 (pt) piridopirazinas substituídas como inibidores de syk
MX2013012211A (es) Derivados biciclicos substituidos de metil amina como moduladores de receptores de esfingosina-1-fosfato.
BR112012031340A2 (pt) derivados de cianoquinolina
BR112015023829A2 (pt) composto de amidina e seu uso
BR112014026198A2 (pt) compostos pirazol como inibidores de sglt1
BR112013031791A2 (pt) derivados de ftalazinona-pirrolopirimidinacarboxamida
BR112013027395A2 (pt) inibidores de 17alfa-hidroxilase/c17,20-liase

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B25A Requested transfer of rights approved

Owner name: NYCOMED ASSET MANAGEMENT GMBH (DE)

B25A Requested transfer of rights approved

Owner name: NYCOMED GERMANY HOLDING GMBH (DE)

B25D Requested change of name of applicant approved

Owner name: TAKEDA GMBH (DE)

B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: ASTRAZENECA AB (SE)

B25A Requested transfer of rights approved

Owner name: ASTRAZENECA AB (SE)

B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: ASTRAZENECA AB (SE)

B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7A ANUIDADE.

B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2518 DE 09-04-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.